At least in theory, producing regulatory T cells could promote immune tolerance and prevent the body from rejecting
newly transplanted cells.
Not exact matches
The Boston patients, in contrast, are free of the virus thanks to a combination of a bone marrow
transplant plus continuing antiretroviral drugs to stop
newly donated immune
cells from being infected.
While some previous studies found that maintenance lenalidomide after autologous hematopoietic stem
cell transplant improved overall survival for
newly diagnosed multiple myeloma patients, others showed no benefit to this approach.
For this analysis, 605 patients with
newly diagnosed multiple myeloma and treated with continuous lenalidomide (brand name Revlimid) following autologous stem
cell transplant were compared to 604 patients who were treated with placebo or no maintenance.
Additionally, the
newly described proliferating
cells hold the promise of being able to regenerate a person's own endothelial
cells, even in cases of FECD, as an alternative to
transplanting corneas from a donor.
Without these
cells, the immune system recognizes a
newly transplanted lung as harmful and mounts an attack that eventually can lead to rejection of the organ.
In patients with GVHD,
newly transplanted T
cells from the bone marrow graft attack the
transplant recipient's body.
Dr. Viczian has demonstrated that a single extrinsic factor can transform frog skin
cells into retinal stem / progenitor
cells and, further, that the
newly made
cells could generate an entire functional eye once they were
transplanted to host embryos.
We are part on the
newly launched NIHR Blood and
Transplant Research Unit in Donor Health and Genomics, where we coordinate theme 1 - Determinants of donation - related biomarkers.This theme will address the NIHR BTRU mandate to identify and characterise «genetic, biochemical, lifestyle and other determinants of relevant blood
cell traits... and measures of iron homeostasis, including determinants of the trajectories of these factors over time among donors».
No Association Between Response Rates and Survival in
Newly Diagnosed Multiple Myeloma: Results of a recent meta - regression analysis of 63 randomized clinical trials out of Greece concluded that there was no association between conventional response outcomes, such as complete response (CR) or very good partial response (VGPR), and overall (OS) or progression - free survival (PFS) in patients with newly diagnosed multiple myeloma in populations of patients who received stem cell transplant and those who did
Newly Diagnosed Multiple Myeloma: Results of a recent meta - regression analysis of 63 randomized clinical trials out of Greece concluded that there was no association between conventional response outcomes, such as complete response (CR) or very good partial response (VGPR), and overall (OS) or progression - free survival (PFS) in patients with
newly diagnosed multiple myeloma in populations of patients who received stem cell transplant and those who did
newly diagnosed multiple myeloma in populations of patients who received stem
cell transplant and those who did not.